Prof. Cris S Constantinescu is the co-Editor-in-Chief of touchREVIEWS in Neurology. Cris Constantinescu is Attending Neurologist at Cooper University Hospital, Cooper Neurological Institute, Cherry Hill, NJ, USA, Professor of Neurology at Cooper Medical School of Rowan University, Camden, NJ, USA, and Emeritus Professor of Neurology in the Academic Unit of Mental Health and Clinical Neurosciences at the University of Nottingham, Nottingham, UK. He graduated with an MD from Boston University School of Medicine, USA, in 1988. As a recipient of the physician-scientist award from the National Institutes of Health, USA, he completed a PhD in immunology at the University of Pennsylvania in 1998. He has completed an internship and a residency in neurology and fellowships in neuroimmunology and neurorehabilitation. He was appointed honorary consultant neurologist and senior lecturer in neurology at the University of Nottingham 2000–2001. In 2004, he was appointed Professor of Neurology and Chair in Neurology at the University of Nottingham, a post he held until 2021. He has authored or co-authored over 200 articles in international journals. His research interests are immune regulation in inflammatory diseases of the nervous system, in particular multiple sclerosis, neuroimaging, clinical trials and cognitive neurology. He is currently involved in the care of numerous patients with neuroimmunological and neurodegenerative diseases.

Said R Beydoun, MD, FAAN, is Professor and Division Chief for Neuromuscular Medicine at the Department of Neurology at Keck School of Medicine, University of Southern California (USC). He is Program Director of the Clinical Neurophysiology Fellowship. As a principal investigator, Dr Beydoun has participated in multiple research clinical trials. His clinical and research areas of expertise in the field of neuromuscular medicine include amyotrophic lateral sclerosis (ALS), myasthenia gravis, peripheral neuropathy (including chronic inflammatory demyelinating polyneuropathy), multifocal motor neuropathy and transthyretin-related amyloid neuropathy. He has published in several scientific journals on topics related to neuromuscular diseases and is co-Editor-in-Chief of touchREVIEWS in Neurology. He is an elected fellow of the American Academy of Neurology and a fellow of the American Association of Neuromuscular and Electrodiagnostic Medicine; a member of the medical/scientific advisory board of the Myasthenia Gravis Foundation of America; Medical Director of the Certified ALS Treatment Center of Excellence at Keck USC; and holds board certification by the American Board of Psychiatry and Neurology in neurology, clinical neurophysiology, neuromuscular medicine and pain medicine.

Prof. K. Ray Chaudhuri is Professor of Neurology/Movement Disorders at King’s College Hospital and King’s College London and Director of the Parkinson Foundation International Centre of Excellence at King’s College. He is Chairman of the Industry Engagement Committee, and Co Chair Task force of the Parkinson Wellness committee of the Movement Disorders Society (MDS and Ex Chair Membership and Public Relations Committee of the Movement Disorders Society (MDS), was a member of the MDS Congress Scientific Programme Committee (2013-2017) and is Founder and Ex Chairman and current steering group member of the MDS Non-Motor Parkinson’s Disease Study Group and a member of the MDS-ES Education committee and Evidence Based Medicine committee (Nonmotor symptoms). He was the founder -Editor-in-Chief of the njp Parkinson’s Disease (2020 impact factor >8), Guest Editor for special editions of Frontiers in Neurology and Journal of Parkinson’s Disease, reviewer for all mainstream movement disorders journals as well as JAMA, Neurology, Annals of Neurology, BMJ, Brain, Lancet, and Journal of Neurology, Neurosurgery, and Psychiatry. He serves as an advisor (MHRA health technology and scientific advisor) to the UK National Institute for Health and Care Excellence, NHS England, General Medical Council as well as Parkinson’s UK and Parkinson’s Europe. 

Prof. Chaudhuri is the author of over 500 articles, co-editor of 5 books on Parkinson’s disease and restless legs syndrome, and winner of the British Medical Association Book Awards commendation in 2015 and 2017. He is also the recipient of 2018 Jay Van Andel Award Outstanding Achievement in Parkinson’s Disease Research (pioneering holistic assessments and non-motor subtypes), as well as National Institute for Health Research/Royal College of Physicians award for outstanding research leadership in 2017. He was elected honorary member of the Movement Disorders Society in 2021, Honorary Professor Brasov University, Honorary Professor SRM University, India and received the UK NHS Gold merit award in 2021 for excellence in research and clinical service.  In 2023 he was featured as “role model” in British Medical Journal. He has been a guest lecturer worldwide, including in Japan, China, Taiwan, Vietnam, Thailand, Singapore, Australia, India, Africa, the US, Russia, and Europe. In 2022/2023 he is ranked fourth in the world for Parkinson’s publications/expertise and expertise since 2014 and no 1 in the UK (expertscape: Parkinson’s disease). In 2024, an independent review in Frontiers journal by LI et al rated KRC as the one with most publications globally in nonmotor Parkinson’s since 2013 (Li et al , DOI 10.3389/fnagi.2024.1335550). In 2024 Prof. Chaudhuri will inaugurate the Kings Parkinson Charity dedicated to research to promote day to day care for People with Parkinson and their carers in conjunction with Sir Nicholas Mostyn, founder of the BBC endorsed Movers and Shakers expert patients group.

Born in Fiume (actually Rijeka, Croatia) in 1939, graduated in Medicine at the University of Padova Medical School in 1963; Specialist in Neurology in 1967. During the years 1967-1970 he was Research Fellow at the Institute for Neurochemistry, Columbia University, New York, USA.

Full Professor of Neurology from 1980 and then Director of the Department of Neurosciences of the Medical School of the University of Padova till 2009. He was the Founder and Scientific Director of the Research Hospital for Neurorehabilitation, IRCCS San Camillo, Venice, from 2005 to 2014.

He has been member of the Executive Council of the Italian Society of Neurology and the President of the Italian Society for Parkinson’s Disease; he was a member of the Executive Committee on Extrapyramidal Disorders, chaired by Melvin Yahr, and after by Donald Calne, and of the one on Dementia of the World Federation of Neurology and, in 2009, Chairman of the Research Group for Organization and Delivery of Neurological Services;  he has been  elected at the WCN in London Vice-President for Europe of the World Federation of Neurology for the years 2001-2005; also, he has been the President of the European Society for Clinical Neuropharmacology during the years 2000-2008; he is a member of numerous International Scientific Societies, and Fellow of the American Academy of Neurology. He has been also a member of the Editorial Board of international journals of neuroscience and clinical neurology.

He has organized various International Congresses and Symposia on specific themes of neuroscience; he was the President of the 11th World Congress on Parkinson’s Disease that was held for the first time in Italy, Rome, in 1994, and President of the 2nd World Congress on Neurorehabilitation held in Venice, in 2002, when the World Federation on Neurorehabilitation was founded; also, he has been the Honorary President of the XXV World  Congress of Neurology held in Rome, Italy, in October 2021.

He has published more than 300 papers in various international and national journals and edited ten volumes on specific arguments of neurology; his main scientific interests have always been cerebral metabolism and function especially in degenerative diseases of the nervous system, like Parkinson’s and Alzheimer’s disease, as well as in cerebrovascular diseases and in neurorehabilitation.

Stewart J Tepper, MD, FAHS is Vice President of the New England Institute for Neurology and Headache (NEINH) in Stamford, Connecticut and Professor of Neurology at the Geisel School of Medicine at Dartmouth. Dr Tepper received his undergraduate degree in the study of the nervous system/psychobiology from Yale and attended Cornell University Medical College. He completed his Neurology residency at Harvard.

Dr Tepper has published more than 480 peer-reviewed manuscripts, editorials, and books on Headache Medicine. He serves on the Executive Board of Directors and is the Corporate Liaison for the American Headache Society. He also serves on the AHS Education, Exhibits, and Finance Committees and on the Governance Committee for the American Migraine Foundation.

Kazuo Fujihara, M.D. is a Professor in the Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, and Director, Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan. Dr. Fujihara has mainly worked in the field of multiple sclerosis (MS), neuromyelitis optica (NMO) and related neuroimmunological disorders. He is a member of the International Panel on Diagnosis of MS (the 2010 and 2017 revisions to the McDonald Criteria), NMO (the 2015 International Consensus Diagnostic Criteria of NMOSD) and MOGAD (2022). Since 2013, he has served on the Executive Committee, International Medical and Scientific Board of The Multiple Sclerosis International Federation (MSIF), and the Board of European Charcot Foundation (ECF). He is an inaugural member and President (2018~) of Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), President (2019~) of Japanese Society for Neuroimmunology (JSNI), an honorary member of The Association of Sri Lankan Neurologists (2012~), Indian Academy of Neurology (2015~) and Hong Kong Society of Multiple Sclerosis (2015~), an Editorial Board member of Neurology: Neuroimmunology and Neuroinflammation (2018~), Multiple Sclerosis and Related Disorders (2020~) and Neuroimmunology Reporsts (2021~), and Associate Editor of Frontiers in Neurology (section Multiple Sclerosis and Neuroimmunology, 2017~) and Multiple Sclerosis Journal (2019).

Dr Erin Furr-Stimming joined the Neurology faculty as an Assistant Professor in 2007 after completing her internship, residency and fellowship at McGovern Medical School-UTHealth. Her clinical expertise is evaluating and treating patients with Huntington’s disease (HD), Parkinson’s disease, atypical parkinsonian syndromes, focal and generalized dystonia, essential tremor and spasticity.

From 2011-2017, Dr Furr-Stimming she served as Chief of Neurology at Lyndon Baines Johnson (LBJ) Hospital. In 2016, she was awarded 1 of 39 designated Level 2 Huntington’s Disease Society of America (HDSA) Centers of Excellence in the country and the only one in Texas. She has focused her clinical efforts on helping those with this devastating neurological disorder and raising awareness through education. She is currently an Associate Professor and is also Director of the Neurology Clerkship Program.

Dr Jessica Ailani is the Director of the Medstar Georgetown Headache Centre, Vice Co-Chair of strategic planning for Medstar Neurology and a Professor of Clinical Neurology at Medstar Georgetown University Hospital in Washington, D.C. Dr Ailani completed her Neurology training at NYU in New York, NY and a headache fellowship at the Jefferson Headache Centre in Philadelphia, PA. Dr Ailani is on the board of the American Headache Society, as a member-at large, the co-chair of the Practice Management committee and the Next Generation Migraine Treatment Education committee, vice chair of the Leadership committee, and serves on the Scottsdale meeting planning committee, scientific meeting planning committee, and Emerging Leaders committee of the American Headache Society.  She is an advisor to the National Headache committee.  She is dedicated to improving the care provided to patients with headache disorders.

Dr Nitin Butala is an Assistant Professor and Clerkship Director for neurology for medical students at The Lake Erie College of Osteopathic Medicine (LECOM). He works as a neurologist and neurophysiologist with Baptist Neurology, Jacksonville, FL, USA. Dr Butala obtained a Bachelor of Medicine and Bachelor of Surgery at Grant Medical College and Sir JJ Group of Hospitals in Mumbai, India, and a Masters in Biological Sciences at Virginia Tech, USA. He completed a neurology residency and clinical neurology fellowship at the Medical College of Wisconsin, USA. He has been an active member of the American Academy of Neurology and American Academy of Neuromuscular and Electrodiagnostic Medicine. He is an experienced neurologist with a demonstrated history of working in the hospital and health care industry. Skilled in the management of a broad spectrum of neurological disorders. Strong healthcare services professional.

Dr Nortina Shahrizaila is currently Professor of Neurology at the Faculty of Medicine, University of Malaya and Senior Consultant Neurologist at University Malaya Medical Centre in Kuala Lumpur, Malaysia. Her subspecialty clinical and research interests are in the field of neuromuscular disorders, in particular peripheral nerve disorders, amyotrophic lateral sclerosis and clinical neurophysiology.

She is the current Chair of the Clinical Neurophysiology Section, Malaysian Society of Neurosciences. She is also a Board Member of the Inflammatory Neuropathy Consortium, Peripheral Nerve Society and a Task Force member of the Electrodiagnostic Expertise Group for the International GBS Outcome Study (IGOS). She serves as a Medical Advisor to the Malaysian Motor Neurone Disease Society and is also the country delegate for the Pan-Asian Consortium for Treatment and Research in ALS (PACTALS) and the International Federation of Clinical Neurophysiology (IFCN).

Dr Nataliya Titova graduated from Pirogov Russian National Research Medical University (Moscow, Russia) and obtained her PhD thesis with research focused on a controlled cross sectional and prospective study on clinical and neurophysiological evaluation of de novo Parkinson’s disease patients. She thereafter trained to become a specialist in Movement Disorders and is currently working in the department of neurology, neurosurgery and medical genetics at the Federal State Budgetary Educational Institution of Higher Education «N.I. Pirogov Russian National Research Medical University» of the Ministry of Healthcare of the Russian Federation, Moscow, Russia. She is also an overseas faculty at the National Parkinson Foundation International Parkinson Centre of Excellence at Kings College, London. She as an active teacher and researcher in the field of Parkinson’s disease and related conditions and has a special interest in Parkinson’s non-motor pathophysiology, genetics and biomarker driven assessment of natural history. She is leading an international programme on developing strategies for personalised medicine in PD and has published original research on the topic including a recent viewpoint paper in Movement Disorders. She has also co-edited a landmark Elsevier, 2700-page book addressing the hidden face of non-motor symptoms of Parkinson’s disease. She has recently joined the editorial board of NPJ Parkinson’s Disease (Nature Partnership Journal) as assistant editor and also serves on the editorial board of European Neurological Review. She is also coauthor on several papers on PD pathophysiology and an active member of the Movement Disorders Society PD non motor study group (trainee section) where she is due to become Chair in 2018. More recently she was elected as a member of the Movement Disorders Society Membership and Public Relations committee. She has lectured on non-motor aspects of PD as well as advanced therapies of PD in Russia, Kazakhstan, London, Romania and India, and most recently was faculty at the International Summit on advanced Parkinson’s disease, held in Berlin, 2017.

George T Grossberg completed a medical degree at the St. Louis University School of Medicine in Missouri. His postdoctoral training included an internship at St. John’s Mercy Medical Center and a residency in the St. Louis University Department of Psychiatry.

A Diplomat of the National Board of Medical Examiners and a Distinguished Fellow of the American Psychiatric Association, Dr Grossberg holds membership in several professional societies. Additionally, he started the first Geriatric Psychiatry program in Missouri, as well as the first Alzheimer’s Disease Community Brain Bank. He is a former president of the American Association of Geriatric Psychiatry and Past President of the International Psychogeriatric Association (IPA). He has been a leader in developing mental health programs and in treatment and research in geriatrics. Among his many awards, Dr Grossberg received the Missouri Adult Day Care Association Outstanding Physician Award for supporting programs that allow seniors to live independently or at home with their families and the Fleishman-Hilliard Award for career contributions to Hilliard geriatrics. He appears regularly on listings of top doctors, including America’s Top Psychiatrists (2008–2016), America’s Top Doctors (2006–2016), Best Doctors in America, and Best Doctors in St. Louis since their inception.

Dr Grossberg has edited and written 14 books and published over 500+ articles, chapters, and abstracts in the peer-reviewed literature. In 2007 he published The Essential Herb-Drug-Vitamin Interaction Guide: The Safe Way to Use Medications and Supplements Together and in 2017, Psychiatric Consultation In Long-Term Care. He currently serves as medical editor of CNS Senior Care and Section Editor for Geriatric Psychiatry, for Current Geriatric Reports and Current Psychiatry. He is on the editorial boards of Demencia Hoy, International Journal of Alzheimer’s Disease, Journal of Alzheimer’s Disease and Parkinson’s and the Journal of the American Medical Directors Association. He is a consultant in the development of protocols for central nervous system disorders in older patients, and he is involved in a variety of basic as well as clinical research projects in the area of dementing disorders, with a focus on behavioral disturbances in dementia.

German X-Ray society, German Society for Neuroradiology, European Society for Neuroradiology

Richard Alan Rison is the general neurology section editor for touchREVIEWS in Neurology, deputy editor of the Journal of Medical Case Reports; an associate neurology editor of BMC Neurology, Grand Rounds, and WebmedCentral; and lead editor for case reports of BMC Research Notes. Dr Rison practices general neurology at Neurology Consultants Medical Group, serves as medical director of the PIH Health Hospital-Whittier Stroke Program and the PIH Health Hospital-Whittier Non-Invasive Vascular Laboratory, is a clinical assistant professor of neurology at the University of Southern California Keck School of Medicine and Los Angeles County Medical Center, and is a fellow of the American Association of Neuromuscular and Electrodiagnostic Medicine. Dr Rison is board-certified by the American Board of Psychiatry and Neurology in neurology and vascular neurology, and neurocritical care and neuroimaging by the United Council of Neurologic Subspecialties. He is also board-certified by the American Board of Electrodiagnostic Medicine in electrodiagnostic medicine. Dr Rison is a former president of the Los Angeles Neurological Society and is a fellow of the American Academy of Neurology and the American Neurological Association.

Dr John Bodensteiner was Consultant in Child and Adolescent Neurology at Mayo in Rochester until July 2017.
Dr John Bodensteiner is the William Pilcher Endowed Chair and Chief of the Pediatric Neurology Division at Barrow.
Dr Bodensteiner served as president of the Child Neurology Society from 2007–2009, and has served in leadership positions in many other capacities during his career in academic paediatric neurology. He has authored or co-authored over 400 scientific publications. His clinical interests include neuromuscular diseases and genetic syndromes affecting children.

Dr Ferro’s main scientific areas of research are stroke, clinical epidemiology, vascular dementia, vascular cognitive impairment, headache, secondary stroke prevention, clinical decision analysis, cerebral vein thrombosis and subarachnoid haemorrhage.

Dr Ferro has led and leads various research projects, such as the International Study of Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Moreover, he was a member of the Steering Committees of the EAFT, ESPS II, TESS II, TACIP, SCOPE, FOP/ASIA and SAFE II studies, as well as a member of the Scientific Committees of the European Stroke Conference, the 3rd and 4th World Stroke Conference, and the Programme Committee of the Stroke Conference. He was conference chairman of the 10th European Stroke Conference. He is also a member of the EUSI Writing Group.

Dr Ferro was a member of the Scientific Committees of the European Stroke Conference, the 3rd and 4th World Stroke Conference, and the Programme Committee of the Stroke Conference. He was conference chairman of the 10th European Stroke Conference. He is also a member of the EUSI Writing Group.

Professor Goadsby specialises in the diagnosis and treatment of headache disorders, including migraines and cluster headache and other forms of chronic daily headaches and has authored 400+ peer reviewed publications.

He is currently Chair of the British Association for the Study of Headache. He is a Professor of Neurology and Director of NIHR Clinical Research Facility at King’s College Hospital in London, UK.

Professor Wen’s research is directed towards the development of new therapies for brain tumors and leptomeningeal metastases using gene therapy, inhibitors of angiogenesis, hormonal therapy and radionuclides. He is also interested in the neurologic complications in cancer patients.

Dr Silberstein lectures extensively on the pathogenesis, neurobiology, diagnosis, and treatment of headache. He has published 300+ peer reviewed articles and is the Senior Editor of the 8th edition of Wolff’s Headache and Other Head Pain.

He is a Fellow of the American College of Physicians, the American Academy of Neurology, and the American Headache Society. He has served the American Headache Society as President, Treasurer, and Board of Directors member. He has served on the Publications, Scientific, and Education Committees of the American Headache Society and was Co-chairman of the Annual Scientific Meeting. Dr Silberstein is an active member of the American Academy of Neurology and is Co-director of the national and international Headache Guideline Project, in cooperation with the Agency for Health Care Policy and Research. He was the Chairman of the International Headache Society meeting in Philadelphia in 2009. He is Chairman of the headache research group of the World Federation of Neurology.

Awards and honors include: Philadelphia Magazine’s Top Docs 2014, 2013,2012,2011,2010.

Dr Stuart Isaacson directs the Parkinson’s disease and Movement Disorders Center of Boca Raton, a nationally recognized leading clinical research institution that brings community access to phase 2 and phase 3 FDA-regulated clinical research trials testing new treatments for improving the symptoms of Parkinson’s disease and trying to slow its progression. He is the author of 100+ peer reviewed publications.

Dr Friedman is a Professor of Neurology & Neurotherapeutics and Ophthalmology at the University of Texas Southwestern Medical Center, where she directs the Headache and Facial Pain Program and the Integrated Project Team for Intracranial Pressure Disorders. She is Board Certified in Neurology and Headache Medicine. She has a Masters in Public Health degree from the University of Rochester with a focus on clinical research. She served on the executive and steering committees of the Neuro-Ophthalmology Research and Disease Investigator Consortium (NORDIC) and the Idiopathic Intracranial Hypertension Treatment Trial.

She is Fellow of the American Academy of Neurology, the American Headache Society, the American Neurological Association and the North American Neuro-Ophthalmology Society (NANOS). She is the past chair of the Headache and Facial Pain section of the American Academy of Neurology, serves on the Board of Directors of the American Headache Society and is a Past-President and Board Chair of NANOS. She has been elected to the “Best Doctors in America” yearly since 1998 and US News and World Report Top Doctors since 2011.

Dr Friedman received her undergraduate degree in Engineering Science at the Georgia Institute of Technology and her medical degree at Tulane University School of Medicine. She completed her Neurology residency at Baylor College of Medicine, and a two-year Neuro-Ophthalmology clinical and research fellowship at the University of Southern California. Prior to joining UT Southwestern, she served on the faculty at SUNY Upstate University and the University of Rochester.

Her publications include over 100 articles in peer-reviewed journals and 22 book chapters. Many of the articles are related to headache disorders including migraine and idiopathic intracranial hypertension. Her key interests are disorders of intracranial pressure, cluster headache and migraine.

Vice President (2018–19), Secretary General, European Academy of Neurology (EAN). Netherlands Organisation for Health Research and Care Innovation.

Vice-President and Chief Scientific Officer (2018-19), American Parkinson Disease Association (APDA)

President (2018–19), International Organization of MS Nurses (IOMSN)

German Multiple Sclerosis Society, President (2018–19), European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)

Mark Freedman is Professor of Medicine (Neurology) at the University of Ottawa, Senior Scientist at the Ottawa Hospital Research Institute and Director of the Multiple Sclerosis Research Unit at the Ottawa Hospital-General Campus.

His extensive research includes molecular neurochemistry, cellular immunology, and clinical studies in MS. His basic science interest concerns immune mechanisms of damage in MS, with a particular interest in the role of the innate immune system such as gamma-delta T-cells. His main clinical interests are cell-based therapies for MS. He was the lead investigator of the Canadian Bone Marrow Transplant Study in MS and co-head in an international study of mesenchymal stem cells for the treatment of MS. He is the current Treasurer of ACTRIMS and a member of American Neurological Association (FANA) and American Academy of Neurology (FAAN).

Professor Werner Poewe is Professor of Neurology and Director of the Department of Neurology at Medical University Innsbruck, Austria since 1995.

Professor Poewe’s main research interests in the field of movement disorders are focused on differential and early diagnosis of Parkinson’s disease, its natural history and pharmacological treatment. He has been involved in the steering committees of numerous drug trials in different stages of Parkinson’s disease for the past 20 years and has authored and co-authored more than 650 original articles and reviews in the field of movement disorders.

Professor Poewe served as President of the Austrian Society of Neurology from 2002–2004 as well as as President of the Austrian Parkinson’s Disease Society from 1996–2009. He has been awarded Honorary Membership of the German Society of Neurology as well as the Japanese Society of Neurology and the International Parkinson & Movement Disorder Society. His awards include the Walther-Birkmayer-Prize of the Austrian PD Society, the Dingebauer-Prize of the German Neurological Society as well as the Research Excellence Award of Innsbruck Medical University.

Professor Poewe served as President of the International Movement Disorder Society from 2000–2002. Professor Poewe took over as Chair of the MDS European Section from 2011–2013 and is currently active as member of the Managing Board of the Movement Disorder Scientific Panel of the European Academy of Neurology.
He has served on the Editorial Board of international neurology journals, including Movement Disorders, Journal of Neurology and European Journal of Neurology and is a regular reviewer for major journals, like Lancet Neurology, Brain, Movement Disorders, Neurology and Annals of Neurology.

Joaquim Ferreira completed his medical degree and PhD in Neurology at the University of Lisbon. He is Professor of Neurology and Clinical Pharmacology at the Faculty of Medicine, University of Lisbon and Head of the Laboratory of Clinical Pharmacology and Therapeutics. He is also the Head of CNS- Campus Neurológico Sénior in Portugal.
He became interested in movement disorders during his medical degree and later undertook a Clinical Pharmacology fellowship with Prof. Olivier Rascol in Toulouse, France.
He is currently the past-chair of the European Section of the International Parkinson and Movement Disorder Society. His major research interests are neuropharmacology, Parkinson’s disease, dystonia and Huntington’s disease.

Aksel Siva currently works as Professor of Neurology, at the Department of Neurology of Istanbul University, Cerrahpaşa School of Medicine where he was the past-chairman, and continues to head the Clinical Neuro-immunology Unit & Multiple Sclerosis Clinic, and acts as senior advisor of the Headache Clinic.

He served as President of the Turkish Neurological Society (TNS) for three consecutive terms 2003–2009, and is the chair of its scientific committee. He is a founding member of the Turkish Multiple Sclerosis Society and the MS Chapter of the TNS. He has served as an executive committee member of the European Neurological Society (ENS) 2009–2014 and currently is a member of the EAN scientific programme committee (2014–2018). He served on the Education Committee of the World Federation of Neurology (WFN) and currently is the chair of the WFN Standards & Evaluations Committee. He is a member of the European Academy of Neurology, American Academy of Neurology, American Neurological Association and European Headache Federation.

His areas of research interest and work are: clinical neuro-immunology, mainly multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), radiologically isolated syndrome (RIS) and neuro-Behçet’s syndrome. He is also involved in clinical work in headaches and neuro-epidemiology. He has authored over 100 peer-reviewed articles and has written many book chapters, and gives lectures as an invited speaker at national and international meetings and institutions.

Dr Farlow is Professor Emeritus of Neurology and Vice-Chairman of Research in the Department of Neurology at the Indiana University School of Medicine in Indianapolis. He is also Associate Co-Director of the Indiana Alzheimer’s Disease Center in Indianapolis and leads a large Alzheimer and related dementias clinical trials site in the Department of Neurology and has lead and/or contributed in various ways to over 150 clinical trials over the last 25 years. Dr Farlow received his medical degree from Indiana University School of Medicine and completed an internship in medicine and residency in neurology at the Indiana University Hospitals. Dr Farlow is a member of many professional associations including AAN, ANA and AGS. He is also a founding member in both the American Society of Experimental Neurotherapeutics and the International Society for CNS Clinical Trials and Methodology. Dr Farlow has lectured on the topics of aging, dementia, and Alzheimer’s disease at more than 300 meetings, conferences, and hospitals/medical schools throughout the world. He is a reviewer for numerous scientific journals and on the editorial boards of MedLink and Current Alzheimer Research. A prolific author, Dr Farlow has presented more than 467 abstracts at professional meetings and has authored or co-authored more than 455 articles published in peer-reviewed journals such as Lancet Neurology, Annals of Family Medicine, and Journal of the American Geriatrics Society. Dr Farlow’s research focuses on clinical trials of investigational drugs for the treatment of Alzheimer’s disease and related dementias being the lead investigator for several major studies including; tacrine, donepezil, rivastigmine, CAD106, solanezumab and has interests in trial design and safety. Dr Farlow also has clinically characterized and helped determine genetic linkage for several familial dementias including the second mutation associated with autosomal dominantly inherited Alzheimer’s disease, Gerstmann-Straussler- Scheinker disease and Multi Systems Tauopathy with Dementia.

Professor Winblad is involved in the European Alzheimer Disease Consortium (EADC), KI-Alzheimer Disease Research Center in Huddinge including KASPAC (KI Dainippon Sumitomo Alzheimer Center), Swedish Brain Power research network.

Prof. Murat Emre was born in 1956, in Eregli, Turkey. After studying medicine at the Istanbul Faculty of Medicine he was trained in neuroscience and clinical neurology at the University of Zürich. He then worked in the fields of neurorehabilitation and clinical research in Switzerland for several years. He trained in movement disorders with Prof. David Marsden at the Queen Square National Hospital for Nervous Diseases, London and in behavioural neurology with Prof. Marsel Mesulam at the Beth Israel Hospital and Harvard Medical School. In 1996 he was assigned as Professor of Neurology at the İstanbul Faculty of Medicine, Department of Neurology, where he started the Behavioural Neurology and Movement Disorders Unit. His research interests are in Parkinson’s disease and related disorders, in particular cognitive aspects of the disease, Alzheimer’s disease and related dementias. He has authored or co-authored 125 articles and book chapters, and he has been the Editor of several books.

Carl Sadowsky, M.D. is Clinical Professor, Division of Neurology, at Nova Southeastern University in Fort Lauderdale, Florida.

Dr Sadowsky received his medical degree from Cornell University Medical College. He completed an internship and residency in internal medicine and a residency in neurology, including a chief residency at Dartmouth-Hitchcock Medical Center in Hanover, New Hampshire.

Dr Sadowsky has participated in numerous clinical trials evaluating the safety and efficacy of various cholinesterase inhibitors in the treatment of Alzheimer’s Disease (AD). He is also a frequent presenter at medical meetings and symposia and a prolific writer. His articles have appeared in such prestigious journals as the Journal of the American Medical Association, Neurology, and Archives of Neurology. His most recent research has focused on comparison of agents used in the treatment of patients with AD, the molecular mechanisms of AD, amyloid imaging in dementia, and ethical issues associated with patient care.

A Fellow of the American Academy of Neurology, Dr Sadowsky is also on the board of the Southeast Florida Alzheimer’s Association. Among his career distinctions, Dr Sadowsky is listed in Best Doctors in America and Best Doctors in America, Southeast Region.

Dr Anna Sauerbier is a clinical research fellow at the National Parkinson Foundation International Centre of Excellence, King’s College Hospital, London having received her medical degree from the Justus-Liebig University in Gießen, Germany. Her research interests are the non- motor aspects of movement disorders (clinical and imaging), with a focus on the impact of ethnicity on the expression of non-motor symptoms in Parkinson’s disease. She has published several peer-reviewed papers and book chapters and has presented at international meetings. She is currently working on her PhD project titled: “Range and nature of non- motor symptoms in people with Parkinson’s: exploring possible ethnic differences between white Caucasian, black African/Caribbean and South Asian population in London, UK.” at King’s College London. She is the treasurer of the European Association of Young Neurologists and Trainees (EAYNT), the representative of the EAYNT in the liaison committee and an associate member of the International Parkinson and Movement Disorder Society (IPMDS).

Professor Scarpini is chief of the Alzheimer Centre of the University of Milan, Ospedale Policlinico. He is particularly interested in clinical and pharmacological aspects of dementias and is involved in many clinical trials with disease-modifying drugs. He is the author of 300+ peer reviewed publications.

Elio Scarpini is a member of the Executive Committee of the European Neurological Society.

Professor Reichmann’s research interests include neuromuscular disorders, extrapyramidal movement disorders and neurosarcoidosis, disorders of energy metabolism in brain and muscle.

He is affiliated with a number of organisations, including President of the European Neurological Society and a member of the following professional associations: the first Chairman of the German Society of Neurology, the second President of the German Parkinson Society, Fellow of the Royal College of Physicians, Subcommittee Chair International Memberships American Academy of Neurology, Chair Scientific Advisory Board UK Parkinson, Member Scientific Advisory Group to the European Medicines Agency, American Neurological Association, American Academy of Neurology, Royal Society of Medicine, European Neurological Society, European Federation of Neurology, New York Academy of Sciences, Movement Disorder Society, Muscular Disorder Society, German Society of Neurology (Advisory Board Member), Association of Neurological Intensive Care.

Professor Langdon’s research work centres on psychological aspects of MS and current projects include the efficacy of medication in protecting cognition, cognitive rehabilitation, cognitive profiles in CIS and early MS and cognition in the later stages of MS, including its relation to early disease status.

She is a frequent contributor to international scientific meetings and committees and is a Trustee of the UK MS Trust, with whom she has authored the MS cognition website www.stayingsmart.org.uk.

Dr Kesselring specialises in rehabilitation of patients with diseases of or trauma to the nervous system, e.g. stroke, brain injury, multiple sclerosis, Parkinson’s disease etc. He has authored 140 Original publications and Editor or Co-Author of 15 books, mainly related to Multiple Sclerosis, Neurorehabilitation, and Magnetic Resonance Imaging.

Since June 2005, Jürg Kesselring has served as President of the Swiss Multiple Sclerosis Society. He is also President of the St. Gallen Foundation for Culture. In December 2010 he was elected a member of the International Committee of the Red Cross (ICRC) co-opted, for which he worked as a physician from 1978 to 1982 as part of several missions.

Professor Jenner is Emeritus Professor of Pharmacology and Director of Neurodegenerative Disease Research Centre at King’s College London and has contributed to understanding mechanisms involved in the initiation and progression of nigral cell death in Parkinson’s disease.

Professor Jenner has published more than 600 papers. He is a frequent speaker at international congresses and to lay groups of patients and caregivers.

Professor Jenner’s contribution to research has been recognised through the award of Fellowships of the Royal Pharmaceutical Society, The British Pharmacological Society and King’s College London.

Arne Hagen is past President of Stroke Alliance for Europe. He is also a board member of the European Federation of Neurological Associations and past President of the Norwegian Association for Stroke Survivors. Prior to his stroke in August 1997, he was a Colonel in the Royal Norwegian Air Force. His service in the air force included Aide de Camp for HM King Olav, Commanding Officer at Bardufoss Air Force Station, Chief of the Foreign Liaison Office, Norway and Branch Chief of the NATO headquarters in High Wycombe, UK.

Professor Godefroy’s research is focused on the characterisation of the cognitive deficits in relationship with cerebrovascular diseases. He has authored 150+ peer reviewed articles and several books, including The Behavioural and Cognitive Neurology of Stroke. He is a former representative of the Société de Neuropsychologie de Langue Française (SNLF).

Stefan Evers is Head of the Department of Neurology at the Lindenbrunn Hospital in Coppenbrügge, Germany, and Professor of Neurology and Clinical Neurophysiology at the University of Münster, Germany. Professor Evers also holds a PhD in Musicology. He is Honorary Secretary of the International Headache Society and Chair of the Headache Panel of the European Academy of Neurology. His main research interests are headache, pain, epilepsy, stroke and the link between music and medicine. He has authored 320 original publications, undertakes peer reviews and is Editor or Co-Author of eight books.

Dr De Reuck’s research interests focus on treatment and management of stroke, epilepsy and Parkinson’s disease. He is especially interested in stroke prevention and atrial fibrillation, cerebral blood flow and oxygen metabolism in borderzone and territorial infarcts, CADASIL (Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), the pathophysiology of carotid artery disease and related clinical syndromes, Parkinsonism in patients with cerebral infarcts, and vagus nerve stimulation for refractory epilepsy.

Dr De Reuck is or has been a principle investigator in the Stroke and Atrial Fibrillation Ensemble (SAFE) II study, and in the Piracetam Acute Stroke Study (PASS). He is the chairman of the Congress Programme Committee of the European Federation of Neurological Societies (EFNS) and a member of the European Task Force on Age-Related White Matter Changes. He has authored 500+ peer reviewed publications.

Dr De Reuck is Past President of the European Federation of Neurological Societies (EFNS)

Author of 100+ peer reviewed publications.

Professor Boon is a former member of the executive committee of the European Neurological Society (ENS), former member of the scientific programme committee of the American Epilepsy Society (AES), former chair of the Epilepsy Scientists panel of the European Federation of Neurological Societies (EFNS) and past editor-in-chief of Acta Neurologica Belgica, the official journal of the Belgian Neurological Society and of Seizure, the European Journal of Epilepsy.

Between 2005 and 2010, he served as the president of the Belgian League against Epilepsy, founding chapter of the ILAE. Paul Boon was the president of the Belgian Neurological Society (BNS) between 2009 and 2011.

Professor Boon is currently a member of the scientific committee of the European Federation of Neurological Societies (EFNS), a member of the scientific advisory board and chairman of the epilepsy subcommittee of the European Neurological Society (ENS).

Professor Avanzini’s research is focused on the physiology of the nervous system with emphasis on the major sensory systems, its development and maturation and the cerebral representation of musical activities. He has conducted numerous studies on epilepsy with special reference to genetic factors and the cellular and molecular mechanisms that drive it. He has authored 200+ peer reviewed publications and several books.

Numerous honours including the 2000 Annual Epilepsy Research Award from the American Epilepsy Society and the 2006 European Epileptology Award of the International League against Epilepsy.

Giuliano Avanzini is Past President of the International League Against Epilepsy (ILAE). He has been a member of the executive committee of the ILAE since 1993, where he previously held the positions of Vice-President and Treasurer.

Cheryl Waters has authored numerous articles and book chapters and a book just printed in its sixth edition: Diagnosis and Management of Parkinson’s Disease. She has been an investigator in numerous studies involving a variety of new medical and surgical treatments. She is the first to hold the Albert B. and Judith L. Glickman Chair in Neurology.

Professor Toga’s research focuses on neuroimaging, informatics, mapping brain structure and function, and brain atlasing. I developed multimodal imaging and data aggregation strategies and applied them in a variety of neurological diseases and psychiatric disorders. He has authored 500+ peer reviewed articles and several books.

Dr Schulder has been the principal investigator on trials pioneering new methods of image guidance for neurosurgery, including the incorporation of functional MRI as well as intraoperative MRI. He has received substantial foundation and industrial grant support for his research.

Dr Schulder is past president of the American Society for Stereotactic and Functional Neurosurgery; founding vice-president of the Intraoperative Imaging Society; secretary-treasurer of the World Society for Stereotactic and Functional Neurosurgery; past president of the Section on History of the American Association of Neurological Surgeons; and an elected member of the American Academy of Neurological Surgery and the Society of Neurological Surgeons.

He has authored more than 70 peer-reviewed articles, 31 abstracts, 17 book chapters and over 200 presentations at national and international meetings. He is the editor of the Handbook of Stereotactic and Functional Neurosurgery. He has received the Leonard Tow Award for Humanism in Medicine and has been elected to the Gold Humanism Honors Society. He has been named as one of the top doctors in the New York metropolitan area annually for over a decade.

Dr Schreiber’s research focuses on the molecular mechanisms underlying selective neuronal degeneration, a major pathological feature of Alzheimer’s, Parkinson’s and other age-related neurodegenerative diseases. He has published over 100 peer reviewed articles.

Affiliated with the following societies: American Neurological Association, American Academy of Neurology, American Society of Neurorehabilitation, Society for Neuroscience and American Association for the Advancement of Science.

Professor Richerson’s research is focused on sudden death in epilepsy (SUDEP) and infants (SIDS), GABA mechanisms in epilepsy, non-motor symptoms of Parkinson’s disease, control of breathing, sleep, serotonin, and brainstem mechanisms. He is the author of 65 peer reviewed publications.

Dr Marsh has research and clinical expertise in neuropsychiatric disorders and brain imaging research and specific expertise in the psychiatric aspects of Parkinson’s disease and epilepsy. She has authored over 100 peer reviewed articles and is a member of the scientific advisory boards for the American Parkinson’s Disease Foundation and the National Parkinson’s Foundation. Dr Marsh is also listed as one of the best doctors in the nation in the field of psychiatry.

Dr Lublin is an internationally renowned authority on the clinical and scientific aspects of multiple sclerosis and one of the foremost experts in experimental therapies.

Dr Lublin is the author of nineteen chapters, 136 publications and one text, and is a member of a number of medical societies including: the National Multiple Sclerosis Society; the MSSM General Clinical Research Center Advisory Committee; and the Executive Committee of the International Medical & Scientific Board of the Multiple Sclerosis International Federation.

Dr Lublin has been listed in “Who’s Who in Frontiers of Science and Technology” and New York Magazine’s “Best Doctors” issue every year since 2000.

Previously Co-Director of the NYU Comprehensive Epilepsy Center and Director of epilepsy research, Prof. Kuzniecky is now Professor and Vice Chairman, Academic Affairs, and Director, Clinical Research Program, Department of Neurology, Hofstra Northwell Health School of Medicine. He has authored over two hundred books, chapters, and journal articles on a number of topics related to epilepsy, and has received epilepsy research grants from the NIH and numerous foundations. His research focuses on brain imaging and malformations of brain development and epilepsy.

Dr Kuzniecky has been recognized for his efforts in the “Best Doctors in America” multiple times and with many honorary lectures around the world.

Professor Kase’s research interests have been in the area of cerebrovascular diseases, performing clinical studies and clinico-pathologic correlations in intracerebral hemorrhage and cerebral infarction. He has authored 100+ peer reviewed publications.

Professor Kase is a member of the American Medical Association, American Academy of Neurology, Stroke Council of the American Heart Association, American Neurological Association, and International Stroke Society. Honorary Member of the Spanish Society of Neurology. Corresponding Member, Chilean Society of Neurology, Neurosurgery, and Psychiatry.

Dr Kalb is the Vice president of the Professional Resource Center at the National Multiple Sclerosis Society in New York City, developing and providing educational materials and consultation services for healthcare professionals.

Dr Kalb has authored or edited a number of publications about multiple sclerosis. She is the author of Families Affected by Multiple Sclerosis: Disease Impacts and Coping Strategies, a monograph published in 1995 by the National MS Society and of the Society’s Knowledge is Power series for individuals newly diagnosed with MS. She is also the editor of the Society’s booklet series for health professionals entitled Talking with Your MS Patients about Difficult Topics, and serves on the editorial board of Keep S’myelin, the newsletter for children who have a parent with MS. Dr Kalb has edited two books–Multiple Sclerosis: The Questions You Have, The Answers You Need, published in its third edition in 2004, and Multiple Sclerosis: A Guide for Families.

Dr Hanley’s expertise is in the area of acute brain disorders including: stroke, brain haemorrhage, coma and brain infections. This includes the emergency management, preoperative, postoperative and long-term care of severe brain disorders. He is the author of 200+ peer reviewed articles.

Dr Hanley is a member of the American Academy of Neurology, the American Neurological Association, the American Physiologic Society, and the Society of Critical Care Medicine. He has received the Alexander Humboldt Research Prize for accomplishments in Brain Injury Research.

Dr Hafler is a clinical scientist with a research interest in understanding the mechanism of autoimmunity with a particular interest in inflammatory central nervous system diseases, with over 300 publications in the field of autoimmunity and immunology.

Dr Hafler has been elected to membership in the American Society of Clinical Investigation, The American Neurological Association, the Alpha Omega Society, and was a Harvey Weaver Scholar of the National Multiple Sclerosis Society.

He received the 1st National Multiple Sclerosis five year Collaborative Center Award for tackling the MS genetic effort.

Dr Grotta’s research focuses on development of new therapies for acute stroke patients. He has been funded by the National Institutes of Health (NIH) for laboratory studies on the biology of brain injury and recovery in animal stroke models. He has played a leadership role in many clinical research studies of both thrombolytic drugs and cytoprotective agents after stroke, including an NIH program project to carry out a series of novel pilot studies aimed at amplifying the existing benefits of intravenous TPA (Tissue Plasminogen Activator). Formerly chairman of Neurology at UT Medical School in Houston, and founder of its stroke clinical and training program, in 2014 he launched the nation’s first Mobile Stroke Unit, an ambulance equipped with a CT scanner and on-board expertise to carry out acute stroke diagnosis and treatment on-scene, thereby saving up to an hour of time. He is funded by the American Heart Association and the Patient Centered Research Institute to conduct a comparative effectiveness study of outcomes with Mobile Stroke Unit vs Standard Management.

Dr Grotta has authored more than 350 articles in peer-reviewed journals.
He was a recipient of the Feinberg Award for Excellence in Clinical Stroke (1999), Physician of the Year (2006), and the Eugene Braunwald Academic Mentorship Award (2010), all from the national chapter of the American Heart Association (AHA), and awards for teaching excellence at UT Medical School.

Dr Furlan has published more than 150 research papers in peer-reviewed journals, and multiple books and book chapters.

Dr Furlan chaired the National Institutes of Health (NIH) Task Force on Hospital Care of Acute Stroke which helped establish hospital guidelines for administration of the clot-dissolving drug tPA. He was co-chair the National Stroke Association Stroke Center Network; founding member of the Brain Attack Coalition; former member of the American Stroke Association Executive Stroke Council, and is a current member of the association’s Stroke Center Advisory Committee.

Dr Furlan is the recipient of the American Heart Association 2000 William M. Feinberg Award for Excellence in Clinical Stroke; the 2004 JCAHO Codman award for improving patient outcomes through systems approaches to stroke care; the 2005 Cleveland Clinic Champion of Quality Award; the 2005 Anthem Impact Business Award; and the 2006 American Heart Association Pacesetter Award for excellence in stroke treatment and research.

Dr Friedlander’s numerous awards include the most prestigious awards for trainees in neurosurgery from both the Congress of Neurological Surgeons and the American Academy of Neurological Surgeons. In addition, he has received the Bayer Cerebrovascular Award and the International Charcot Prize for Motor Neuron Diseases.

Dr Friedlander is the recipient of the 2012 H. Richard Winn, MD Prize from The Society of Neurological Surgeons. He is an elected member of the American Academy of Neurological Surgeons, The Society of Neurological Surgeons, The American Society for Clinical Investigation (one of five neurosurgeons), and the Association of American Physicians (one of two neurosurgeons).

Professor Antonini’s research focuses on pharmacology of dopaminergic medications, neuroimaging as well as cognitive and behavioural aspects of Parkinson’s disease. In addition he is actively involved in the use of continuous infusion of levodopa and apomorphine as well as subthalamic nucleus deep brain stimulus (STN-DBS) for the treatment of motor fluctuations and dyskinesia of complicated Parkinson patients.

During his academic career he has published almost 200 peer-reviewed manuscripts and several book chapters. He has many society affiliations, including treasurer of the Association of Parkinsonism and Related Disorders.

Dr Cummings is the author of the Neuropsychiatric Inventory (NPI), the most commonly used tool for characterizing behavioural disturbances in dementia syndromes and for measuring the effect of therapies on neuropsychiatric symptoms in Alzheimer’s disease and other dementias.

Dr Cummings is an experienced clinical trialist with expertise in clinical trial design and analysis, global trial implementation, and trial outcome measures. He has published over 600 articles and 35 books on Alzheimer’s disease and related topics.

Dr Cummings’ research and leadership in the field of Alzheimer’s disease have been recognized with many awards, including the Henderson Award of the American Geriatrics Society, the Research Award of the John Douglas French Alzheimer’s Research Foundation, and the Ronald and Nancy Reagan Research Award of the national Alzheimer’s Association. In 2010 he was honored by the American Association of Geriatric Psychiatry with their Distinguished Scientist Award.

Dr Bethoux is a principal or co-investigator in a number of research studies in the area of multiple sclerosis rehabilitation, ambulation, and spasticity management. Dr Bethoux has spoken both nationally and internationally on these topics. Dr Bethoux’s work has been published in many peer-reviewed medical journals. Dr Bethoux also authored several book chapters and co-edited a book on outcome measures for rehabilitation.

Dr Bethoux has contributed to several expert panels. He currently chairs the Research Interest Group on symptom management of the Consortium of Multiple Sclerosis Centers. He is a member of the American Academy of Neurology and of the International Society for Quality of Life Research.